TruSpine Technologies Plc — AGM Information 2025

Apr 10, 2025

National Storage Mechanism | Additional information

RNS Number : 5486E

TruSpine Technologies PLC

10 April 2025

10 April 2025

TruSpine Technologies plc

("TruSpine" or the "Company")

Result of 2024 AGM & Directorate Change

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that at its 2024 AGM held earlier today all resolutions were duly passed.

As announced 17 March 2025, following the conclusion of the 2024 AGM, Norman Lott, Tim Evans and Nikunj Patel have retired from the Board with immediate effect. Dr Evans and Mr Patel will remain as members of the Medical Advisory Board providing continual input on the medical side.

Details of the votes received will be available shortly on the Company's website.

The Directors of the Company are responsible for the release of this announcement.

-END-

TruSpine Investor Hub	https://investorhub.truspinetech.com
TruSpine Technologies Plc	Tel: +44 (0)20 7118 0852
Geoff Miller, Non-executive Chairman
Cairn Financial Advisers LLP (AQSE Corporate Adviser)	Tel: +44 (0)20 7213 0880
Liam Murray / Ludovico Lazzaretti
Peterhouse Capital Limited (Broker & Financial Adviser)	Tel: +44 (0)20 7469 0930
Lucy Williams / Duncan Vasey
Novus Communications (PR and IR)	Tel: +44 (0)1273 704 473
Alan Green / Jacqueline Briscoe	[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXGPUGCCUPAGGU